Title: CO80 Surrogate Endpoints for Overall Survival in Cutaneous Squamous Cell Carcinoma: A Meta-Regression of Clinical Trials
Abstract: Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer. Treatment of advanced CSCC has traditionally been performed with chemotherapies with predominately poor results. Recently Immunotherapy (IO) has shown promising effectiveness, however the overall survival reported from these trials is immature (i.e. median is yet to be reached). This poses challenges for payers and decision makers as economic modelling and evaluation are heavily dependent on overall survival (OS). The objective of this study is to identify surrogate endpoints for OS that can be used to establish whether next generation therapies are cost-effective for CSCC.
Publication Year: 2022
Publication Date: 2022-12-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot